Advertisement
Noxopharm: A wonder drug?
Listen to ASX-listed Noxopharm CEO Dr Graham Kelly talk to Matt Birney on the Bulls N’ Bears Report about Noxopharm’s very scalable universal drug technology that could potentially be used on almost any cancer.
